Trial intelligence / Profile preview

Memantine for Neuroprotection and Cognitive Enhancement in Severe TBI

NCT02240589Completed

Sponsor
Indiana University
Start
Dec 2014
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of memantine in traumatic brain injury (TBI), sponsored by Indiana University. Primary endpoint: California Verbal Learning Test - Second Edition Long Delay Free Recall at 24 weeks. Started Dec 2014; status: completed.

02

Drugs

memantine
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT02240589.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02240589.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call